India's drug regulator, the DCGI, is set to meet with cosmetics industry representatives to address regulatory concerns. The ...
GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback